[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335235-105":59,"doc-detail-335235-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","efficacy-of-a-real-time-intelligent-quality-control-system-for-the-detection-of-early-upper-gastrointestinal-neoplasms-a-multicentre-single-blinded-randomised-controlled-trial","Efficacy of a Real-time Intelligent Quality-control System for the Detection of Early Upper Gastrointestinal Neoplasms - A Multicentre, Single-blinded, Randomised Controlled Trial","","Real-time intelligent quality-control system (IQCS) support was evaluated for improving oesophagogastroduodenoscopy (OGD) quality and detection of early upper gastrointestinal (UGI) neoplasms. A multicentre, single-blinded, randomised controlled trial across six hospitals enrolled patients aged 40–80 years undergoing painless OGD. Participants were assigned 1:1 to routine OGD or OGD aided by IQCS, with masking to randomisation status and per-protocol analysis. IQCS significantly increased early UGI neoplasm detection and improved cleanliness and blind spots, with no reported adverse events.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/efficacy-of-a-real-time-intelligent-quality-control-system-for-the-detection-of-early-upper-gastrointestinal-neoplasms-a-multicentre-single-blinded-randomised-controlled-trial/335235/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/efficacy-of-a-real-time-intelligent-quality-control-system-for-the-detection-of-early-upper-gastrointestinal-neoplasms-a-multicentre-single-blinded-randomised-controlled-trial/335235.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the IQCS aim to solve in OGD practice?","Question",{"text":113,"@type":114},"OGD quality and identification of early upper gastrointestinal neoplasms are important, but the optimal daily quality-control method was lacking. The IQCS was designed to combine OGD quality control with lesion detection.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the trial designed and who were the participants?",{"text":118,"@type":114},"The study was a multicentre, single-blinded, randomised controlled trial at six hospitals in China. Patients aged 40–80 years undergoing painless OGD were screened, with exclusions including prior advanced UGI cancer and stenosis or obstruction.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key outcomes of using IQCS?",{"text":122,"@type":114},"IQCS significantly increased the detection rate of early UGI neoplasms, reduced blind spots, and improved stomach cleanliness at multiple sites. Inspection time and biopsy rate were not different between groups.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335235,1790474897,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Articles   \nEfﬁcacyofa real-time intelligent quality-control system for the detection of early upper gastrointestinal neoplasms: amulticentre, single-blinded, randomised controlled trial  \nRuchen Zhou,a,b,c,d Jing Liu,a,b,c,d Chenchen Zhang,a,b,c,d Yusha Zhao,a,b,c,dJingran Su,a,b,c,d Qiong Niu,e,f Chengxia Liu,e,f Zhuang Guo,g Zhenqin Cui,g Xiaoqin Zhong,h Weidong Zhao,h Jing Li,i Xiaodong Zhang,i Hongyan Wang,j Shidong Sun,j Ruiguang Ma,a,b,c,d Xinyu Chen,a,b,c,d Xinyan Xu,a,b,c,d Yiqing Zhu,a,b,c,d Zhen Li,a,b,c,d,∗ Xiuli Zuo,a,b,c,d and Yanqing Lia,b,c,d  \naDepartment of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China  \nbLaboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China  \ncRobot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, Shandong, China  \ndShandong Provincial Clinical Research Centre for Digestive Disease, Qilu Hospital of Shandong University, Jinan, Shandong, China eDepartment of Gastroenterology, Binzhou Medical University Hospital, Binzhou, Shandong, China  \nfThe First School of Clinical Medicine of Binzhou Medical University, Binzhou, Shandong, China gCentral Hospital of Shengli Oilﬁeld, Dongying, Shandong, China  \nhZibo Municipal Hospital, Zibo, Shandong, China iLinyi People’s Hospital, Dezhou, Shandong, China jPKUCare Luzhong Hospital, Zibo, Shandong, China  \nSummary  \nBackground Oesophagogastroduodenoscopy (OGD) quality and identiﬁcation of the early upper gastrointestinal (UGI) neoplasm play an important role in detecting the UGI neoplasm. However, the optimal method for quality control in daily OGD procedures is currently lacking. We aimed to evaluate the efﬁcacy ofa real-time intelligent quality-control system (IQCS), which combines OGD quality control with lesion detection of early UGI neoplasms.  \nMethods We performed a multicentre, single-blinded, randomised controlled trial at 6 hospitals in China. Patients aged 40–80 years old who underwent painless OGD were screened for enrolment in this study. Patients with a history of advanced UGI cancer, stenosis, or obstruction in UGI tract were excluded. Eligible subjects were randomly assigned (1:1) to either the routine or IQCS group to undergo standard OGD examination and OGD examination aided by IQCS, respectively. Patients were masked to the randomisation status. The primary outcome was the detection of early UGI neoplasms. All analyses were done on a per-protocol basis. This trial is registered [with](with ClinicalTrials.gov)[ ClinicalTrials.gov](with ClinicalTrials.gov), NCT04720924.  \nFindings Between January 16, 2021 and December 23, 2022, 1840 patients were randomised (IQCS group: 919, routine group: 921). The full analysis set consisted of 914 in the IQCS group and 915 in the routine group. The early UGI neoplasms detection rate in the IQCS group (6.1%, 56/914) was signiﬁcantly higher than in the routine group (2.3%, 21/915; P = 0.0001) . The IQCS group had fewer blind spots (2.3 vs. 6.2, P \u003C 0.0001) . The IQCS group had higher stomach cleanliness on cardia or fundus (99.5% vs. 87.9%, P \u003C 0.0001), body (98.9% vs. 88.0%, P \u003C 0.0001), angulus (99.8% vs. 88.4%, P \u003C 0.0001) and antrum or pylorus (100.0% vs. 87.4%, P \u003C 0.0001) . The inspection time (576.2 vs. 574.5s, P = 0.91) and biopsy rate (57.2% vs. 56.6%, P = 0.83) were not different between the groups. The early UGI neoplasms detection rate in the IQCS group increased in both non-academic centres (RR = 3.319, 95% CI 1.277–9.176; P = 0.0094) and academic centres (RR = 2.416, 95% CI 1.301–4.568; P = 0.0034) . The same improvements were observed for both less-experienced endoscopists (RR = 2.650, 95% CI 1.330–5.410; P = 0.0034) and experienced endoscopists (RR = 2.710, 95% CI 1.226–6.205; P = 0.010) . No adverse events or serious adverse events were reported in the two groups.  \nInterpretation The IQCS improved the OGD quality and increased early UGI n","cbCaijJ7ZlpgSFsz","https://ap.wps.com/l/cbCaijJ7ZlpgSFsz","pdf",362350,"English","# Background\n# Methods\n# Findings\n# Interpretation\n# Funding\n# Keywords\n# Research in context","[{\"question\":\"What problem does the IQCS aim to solve in OGD practice?\",\"answer\":\"OGD quality and identification of early upper gastrointestinal neoplasms are important, but the optimal daily quality-control method was lacking. The IQCS was designed to combine OGD quality control with lesion detection.\"},{\"question\":\"How was the trial designed and who were the participants?\",\"answer\":\"The study was a multicentre, single-blinded, randomised controlled trial at six hospitals in China. Patients aged 40–80 years undergoing painless OGD were screened, with exclusions including prior advanced UGI cancer and stenosis or obstruction.\"},{\"question\":\"What were the key outcomes of using IQCS?\",\"answer\":\"IQCS significantly increased the detection rate of early UGI neoplasms, reduced blind spots, and improved stomach cleanliness at multiple sites. Inspection time and biopsy rate were not different between groups.\"}]","Efficacy of a Real-time Intelligent Quality-control System for the Detection of Early Upper Gastrointestinal Neoplasms - A Multicentre, Single-blinded, Randomised Controlled Trial | PDF",1790010260,28]